Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Opko Health Inc (NQ: OPK )

1.300 +0.040 (+3.17%)
Streaming Delayed Price Updated: 3:32 PM EDT, May 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Opko Health Inc

< Previous 1 2 3 4 5 Next >
Why OPKO Health Stock Is Getting Hammered
OPKO Health Inc (NASDAQ: OPK) shares are trading lower by 26.3% to $1.10 Thursday morning. 
Via Benzinga
Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 50 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Opko Health (OPK) Q3 2023 Earnings Call Transcript
OPK earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields
The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Earnings Preview: OPKO Health
Via Benzinga
Opko Health (OPK) Q2 2023 Earnings Call Transcript
OPK earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving Premarket
Gainers RVL Pharmaceuticals plc (NASDAQ: RVLP) shares rose 181.8% to $0.2201 in pre-market trading. 
Via Benzinga
Nike, OPKO Health And Other Big Stocks Moving Higher In Friday's Pre-Market Session
U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
MarketWise And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones closed lower by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
A Preview Of OPKO Health's Earnings
Via Benzinga
Why Opko Health Stock Is Moving Today
Opko Health, Inc. 
Via Benzinga
Opko Health (OPK) Q1 2023 Earnings Call Transcript
OPK earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. 
Via Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Shares of Opko Health Jumped on Thursday
The FDA approved a growth therapy the company was collaborating on with Pfizer. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Recap: OPKO Health Q1 Earnings
Via Benzinga
Why OPKO Health Shares Jumped on Wednesday
A major pharma name is showing interest in one of the company's vaccine prospects. 
Via The Motley Fool
Which Stocks Are Responding To The Strong Jobs Report? 10 Top Movers
The U.S. labor market is sizzling, surpassing all forecasts in May and posting its strongest performance in recent months. 
Via Benzinga
IonQ, Solo Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. OPKO Health, Inc. (NASDAQ: OPK) shares dipped 17.4% to $1.47 in... 
Via Benzinga
OPKO Health And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower on Monday after recording sharp gains on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
Via Benzinga
Stocks React To February Jobs Report: The Winners And Losers
The markets have offered investors a rollercoaster ride this week, with a flurry of activity and developments that have sent shockwaves through various sectors. 
Via Benzinga
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million. 
Via Benzinga
Mesoblast, Arlo Technologies, CPI Card Group And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 30 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.